These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


265 related items for PubMed ID: 23468266

  • 1. L-thyroxine therapy and growth processes in children with Down syndrome.
    Kowalczyk K, Pukajło K, Malczewska A, Król-Chwastek A, Barg E.
    Adv Clin Exp Med; 2013; 22(1):85-92. PubMed ID: 23468266
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of physical development of children with congenital hypothyroidism detected in the screening test--personal observations].
    Kik E, Noczyńska A.
    Pediatr Endocrinol Diabetes Metab; 2011; 17(2):96-106. PubMed ID: 21722516
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of thyroid dysfunctions in infants and children with Down Syndrome (DS) and the effect of thyroxine treatment on linear growth and weight gain in treated subjects versus DS subjects with normal thyroid function: a controlled study.
    AlAaraj N, Soliman AT, Itani M, Khalil A, De Sanctis V.
    Acta Biomed; 2019 Sep 23; 90(8-S):36-42. PubMed ID: 31544805
    [Abstract] [Full Text] [Related]

  • 4. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G, Rapa A, Boccardo G, Silvestro L, Chiorboli E.
    Minerva Endocrinol; 1999 Jun 23; 24(2):51-5. PubMed ID: 10941423
    [Abstract] [Full Text] [Related]

  • 5. Effect of high versus low initial doses of L-thyroxine for congenital hypothyroidism on thyroid function and somatic growth.
    Jones JH, Gellén B, Paterson WF, Beaton S, Donaldson MD.
    Arch Dis Child; 2008 Nov 23; 93(11):940-4. PubMed ID: 18456702
    [Abstract] [Full Text] [Related]

  • 6. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 Nov 23; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]

  • 7. Thyroid dysfunction in HIV-infected children: is L-thyroxine therapy beneficial?
    Rana S, Nunlee-Bland G, Valyasevi R, Iqbal M.
    Pediatr AIDS HIV Infect; 1996 Dec 23; 7(6):424-8. PubMed ID: 11361500
    [Abstract] [Full Text] [Related]

  • 8. [Pituitary hyperplasia secondary to primary hypothyroidism in children: report of 8 cases].
    Xu AJ, Li T.
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jan 23; 12(1):17-20. PubMed ID: 20113627
    [Abstract] [Full Text] [Related]

  • 9. Effect of different starting doses of levothyroxine on growth and intellectual outcome at four years of age in congenital hypothyroidism.
    Salerno M, Militerni R, Bravaccio C, Micillo M, Capalbo D, Di MS, Tenore A.
    Thyroid; 2002 Jan 23; 12(1):45-52. PubMed ID: 11838730
    [Abstract] [Full Text] [Related]

  • 10. Effects of iodine deficiency on insulin-like growth factor-I, insulin-like growth factor-binding protein-3 levels and height attainment in malnourished children.
    Wan Nazaimoon WM, Osman A, Wu LL, Khalid BA.
    Clin Endocrinol (Oxf); 1996 Jul 23; 45(1):79-83. PubMed ID: 8796142
    [Abstract] [Full Text] [Related]

  • 11. IGF-1 and IGFBP-3 in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G, Rapa A, Boccardo G, Silvestro L, Chiorboli E.
    Panminerva Med; 1998 Jun 23; 40(2):103-6. PubMed ID: 9689829
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism?
    Giavoli C, Porretti S, Ferrante E, Cappiello V, Ronchi CL, Travaglini P, Epaminonda P, Arosio M, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 2003 Dec 23; 59(6):806-10. PubMed ID: 14974926
    [Abstract] [Full Text] [Related]

  • 14. Increased neonatal thyrotropin in Down syndrome.
    Myrelid A, Jonsson B, Guthenberg C, von Döbeln U, Annerén G, Gustafsson J.
    Acta Paediatr; 2009 Jun 23; 98(6):1010-3. PubMed ID: 19239410
    [Abstract] [Full Text] [Related]

  • 15. Growth of children with Down's syndrome: birth to age 3 years.
    Cronk CE.
    Pediatrics; 1978 Apr 23; 61(4):564-8. PubMed ID: 149290
    [Abstract] [Full Text] [Related]

  • 16. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM, Simm D, Beier C, Dörr HG.
    Pediatrics; 2006 Jan 23; 117(1):e98-105. PubMed ID: 16396852
    [Abstract] [Full Text] [Related]

  • 17. Euthyroid submedian free T4 and subclinical hypothyroidism may have a detrimental clinical effect in Down syndrome.
    Tenenbaum A, Lebel E, Malkiel S, Kastiel Y, Abulibdeh A, Zangen DH.
    Horm Res Paediatr; 2012 Jan 23; 78(2):113-8. PubMed ID: 22922417
    [Abstract] [Full Text] [Related]

  • 18. [The diagnostics and developmental stimulation of small children with 21 trisomy in compliance with thyroid function].
    Mysłek-Prucnal M, Sadowska L, Gruna-Ozarowska A.
    Pediatr Endocrinol Diabetes Metab; 2008 Jan 23; 14(4):243-7. PubMed ID: 19239793
    [Abstract] [Full Text] [Related]

  • 19. Thyroid function in short children born small-for-gestational age (SGA) before and during GH treatment.
    de Kort SW, Willemsen RH, van der Kaay DC, van Dijk M, Visser TJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Aug 23; 69(2):318-22. PubMed ID: 18221400
    [Abstract] [Full Text] [Related]

  • 20. The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial.
    van Trotsenburg AS, Vulsma T, van Rozenburg-Marres SL, van Baar AL, Ridder JC, Heymans HS, Tijssen JG, de Vijlder JJ.
    J Clin Endocrinol Metab; 2005 Jun 23; 90(6):3304-11. PubMed ID: 15755847
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.